Pargyline has 1 known drug interaction based on U.S. FDA drug labeling data. Of these, 1 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Rizatriptan Benzoate. Patients taking Pargyline should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 1
- Contraindicated
- 1
Contraindicated (1)
- Pargyline + Rizatriptan Benzoate— Nonselective MAO inhibitor contraindicated with rizatriptan due to increased plasma concentrations and potential for ser…